Saag M - Search Results

1

A Randomized Pilot Trial of a Novel Behavioral Intervention for Chronic Pain Tailored to Individuals with HIV.

Merlin JS, Westfall AO, Long D, Davies S, Saag M, Demonte W, Young S, Kerns RD, Bair MJ, Kertesz S, Turan JM, Kilgore M, Clay OJ, Starrels J, Pekmezi D, Johnson MO. Merlin JS, et al. Among authors: saag m. AIDS Behav. 2018 Aug;22(8):2733-2742. doi: 10.1007/s10461-018-2028-2. AIDS Behav. 2018. PMID: 29340913 Free PMC article. Clinical Trial.

2

Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiency virus infection.

Call SA, Saag MS, Westfall AO, Raper JL, Pham SV, Tolson JM, Hellmann NS, Cloud GA, Johnson VA. Call SA, et al. Among authors: saag ms. J Infect Dis. 2001 Feb 1;183(3):401-8. doi: 10.1086/318078. Epub 2000 Dec 29. J Infect Dis. 2001. PMID: 11133371

3

Health-related quality of life and virologic outcomes in an HIV clinic.

Call SA, Klapow JC, Stewart KE, Westfall AO, Mallinger AP, DeMasi RA, Centor R, Saag MS. Call SA, et al. Among authors: saag ms. Qual Life Res. 2000;9(9):977-85. doi: 10.1023/a:1016668802328. Qual Life Res. 2000. PMID: 11332226

4

Immunologic and virologic consequences of temporary antiretroviral treatment interruption in clinical practice.

Chen RY, Westfall AO, Raper JL, Cloud GA, Chatham AK, Acosta EP, Pham SV, Tolson JM, Heudebert GR, Saag MS. Chen RY, et al. Among authors: saag ms. AIDS Res Hum Retroviruses. 2002 Sep 1;18(13):909-16. doi: 10.1089/088922202760265588. AIDS Res Hum Retroviruses. 2002. PMID: 12230934

5

Patient-perceived barriers to antiretroviral adherence: associations with race.

Ferguson TF, Stewart KE, Funkhouser E, Tolson J, Westfall AO, Saag MS. Ferguson TF, et al. Among authors: saag ms. AIDS Care. 2002 Oct;14(5):607-17. doi: 10.1080/0954012021000005434. AIDS Care. 2002. PMID: 12419110

6

Duration of highly active antiretroviral therapy regimens.

Chen RY, Westfall AO, Mugavero MJ, Cloud GA, Raper JL, Chatham AG, Acosta EP, Taylor KH, Carter J, Saag MS. Chen RY, et al. Clin Infect Dis. 2003 Sep 1;37(5):714-22. doi: 10.1086/377271. Epub 2003 Aug 13. Clin Infect Dis. 2003. PMID: 12942406

7

A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: The WiLLOW Program.

Wingood GM, DiClemente RJ, Mikhail I, Lang DL, McCree DH, Davies SL, Hardin JW, Hook EW 3rd, Saag M. Wingood GM, et al. Among authors: saag m. J Acquir Immune Defic Syndr. 2004 Oct 1;37 Suppl 2:S58-67. doi: 10.1097/01.qai.0000140603.57478.a9. J Acquir Immune Defic Syndr. 2004. PMID: 15385901 Clinical Trial.

8

Sustained HIV viral suppression following treatment interruption: an observational study.

Bedimo R, Chen RY, Westfall AO, Raper JL, Allison JJ, Saag MS. Bedimo R, et al. AIDS Res Hum Retroviruses. 2006 Jan;22(1):40-4. doi: 10.1089/aid.2006.22.40. AIDS Res Hum Retroviruses. 2006. PMID: 16438644

9

Distribution of health care expenditures for HIV-infected patients.

Chen RY, Accortt NA, Westfall AO, Mugavero MJ, Raper JL, Cloud GA, Stone BK, Carter J, Call S, Pisu M, Allison J, Saag MS. Chen RY, et al. Among authors: saag ms. Clin Infect Dis. 2006 Apr 1;42(7):1003-10. doi: 10.1086/500453. Epub 2006 Feb 22. Clin Infect Dis. 2006. PMID: 16511767

10

Can routine clinical markers be used longitudinally to monitor antiretroviral therapy success in resource-limited settings?

Bagchi S, Kempf MC, Westfall AO, Maherya A, Willig J, Saag MS. Bagchi S, et al. Clin Infect Dis. 2007 Jan 1;44(1):135-8. doi: 10.1086/510072. Epub 2006 Nov 28. Clin Infect Dis. 2007. PMID: 17143829

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

589 results

Search Page